GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Purchase Of Investment

Chongqing Lummy Pharmaceutical (SZSE:300006) Purchase Of Investment : ¥0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Purchase Of Investment?

Chongqing Lummy Pharmaceutical's purchase of investment for the three months ended in Sep. 2024 was ¥0.0 Mil. It means Chongqing Lummy Pharmaceutical spent ¥0.0 Mil on purchasing investments. Chongqing Lummy Pharmaceutical's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.0 Mil.

Compared with last quarter (¥0.0 Mil in Jun. 2024 ), Chongqing Lummy Pharmaceutical spent the same money on purchasing investments in Sep. 2024 (¥0.0 Mil).


Chongqing Lummy Pharmaceutical Purchase Of Investment Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Purchase Of Investment Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -461.92 -809.46 -92.37 -45.45 -13.25

Chongqing Lummy Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Chongqing Lummy Pharmaceutical Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chongqing Lummy Pharmaceutical Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Lai Wen Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines